Less is more: Academic publishing needs ‘radical change,’ Cambridge press report concludes 

Academic publishing needs “renewed focus and collective action” to embrace new approaches and ensure the future of the industry, concludes a report from Cambridge University Press, released last week. 

What started as an exploration of barriers to open access models turned into a call for “radical change” in academic publishing. “It has been clear for some time that the publishing ecosystem is under increasing strain,” Mandy Hill, managing director of Cambridge University Press, wrote in the introduction to the report. “This was the case before the growth of open access, but it is also clear that the shift to open has not solved the problems, as some early open access advocates may have hoped.”

The report, which followed workshops and interviews with stakeholders, includes results of a survey of more than 3,000 researchers, librarians, funders, publishers and societies. 

Continue reading Less is more: Academic publishing needs ‘radical change,’ Cambridge press report concludes 

Exclusive: Journal to retract Alzheimer’s study after investigation finds misconduct

A journal says it will retract a 2019 paper on an Alzheimer’s treatment after an institutional investigation found research misconduct, according to emails seen by Retraction Watch. The move comes four years after another investigation by the same university uncovered image duplication in a different paper by a similar group of authors.

The paper, published in Biological Psychiatry, describes the potential of an apoE antagonist for treatment in Alzheimer’s disease. 

A 2019 news release by the University of South Florida, home to several of the researchers involved in the study, called the work “promising.” Lead author Darrell Sawmiller, an assistant professor at USF, said the study represented “the first time … we have direct evidence” apoE “acts as an essential molecule” in the mechanisms leading to Alzheimer’s. 

Continue reading Exclusive: Journal to retract Alzheimer’s study after investigation finds misconduct

Weekend reads: Spinal researcher gave patients ‘false hope’; HHS admits error in laying off top ethics official; Alzheimer’s fraud trial set to begin 

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Did you know that Retraction Watch and the Retraction Watch Database are  projects of The Center of Scientific Integrity? Others include the Medical Evidence Project, the Hijacked Journal Checker, and the Sleuths in Residence Program. Help support this work.   

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: Spinal researcher gave patients ‘false hope’; HHS admits error in laying off top ethics official; Alzheimer’s fraud trial set to begin 

Exclusive: Iraqi university forcing students to cite its journals to graduate

To earn their degrees, graduate students at the University of Technology in Baghdad not only must publish research in indexed journals. They also are required to cite articles in their school’s own publications, a document obtained by Retraction Watch shows.

Experts who reviewed the document called the citation requirement “deceptive and despicable” and said it could carry a steep price for the journals involved, one of which is indexed in Scopus.

Coercive citation is widespread in academia and can help boost the rankings of publications, institutions and individual researchers. The practice is considered unethical and may trigger heavy penalties.

Continue reading Exclusive: Iraqi university forcing students to cite its journals to graduate

Controversial Paxil “Study 329” earns expression of concern after critic sues publisher

After more than 20 years of criticism and calls for retraction, a journal has placed an expression of concern on a study of the antidepressant Paxil in teens that critics say has led to unwarranted and potentially harmful prescribing of the drug to youth. 

The 2001 paper, published in the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), reported findings from a randomized trial known as “Study 329,” which concluded the antidepressant Paxil was safe and effective in kids ages 12 to 18. 

In 2012, Paxil maker GlaxoSmithKline agreed to pay $3 billion to settle civil and criminal charges that included “unlawful promotion” of the drug for adolescents, for whom the product was never approved, and allegations the company “participated in preparing, publishing and distributing a misleading medical journal article” — the JAACAP paper.  A reanalysis in 2015 found the drug was “ineffective and unsafe” for the age group studied.

Continue reading Controversial Paxil “Study 329” earns expression of concern after critic sues publisher

Sleuth loses paper for duplicate publication after flagging hundreds of untrustworthy articles

A sleuth who has identified several hundred articles describing clinical women’s health research with untrustworthy data, leading to nearly 300 retractions, has now lost one of his own papers for duplicate publication. 

Ben Mol, who leads the Evidence-based Women’s Health Care Research Group in the department of obstetrics and gynecology at Monash University in Australia, has worked to raise awareness of problematic data informing medical recommendations for women’s health care, and to cleanse the literature of unreliable studies, with major media outlets covering his work. 

Mol told Retraction Watch about 50 of his papers have been investigated since 2020, usually after anonymous complaints. “It is clear that somebody had been screening my papers … in a systematic way to find any wrongdoing,” he said. His only other retraction came after he and colleagues found an error in their own work and requested the action.

Continue reading Sleuth loses paper for duplicate publication after flagging hundreds of untrustworthy articles

Iraqi dean earns another retraction for paper posted for sale on Facebook

Yasser Fakri Mustafa

A dean and professor at a public university in Iraq has lost another paper just weeks after we reported he was up to 16 retractions for authorship manipulation, fake peer review and other problems.

Yasser Fakri Mustafa of the University of Mosul was a coauthor of the newly retracted article, a review of how aerosol boxes affected intubation during the COVID‐19 pandemic. He denied wrongdoing.

As stated in the retraction notice, online September 23, the article’s title matched an authorship ad posted on social media on March 9, 2022, eight months before the paper appeared in Taylor & Francis’ Expert Review of Medical Devices.

Continue reading Iraqi dean earns another retraction for paper posted for sale on Facebook

A peer-reviewed paper claimed a researcher was an expert in sex robots. He’s not.

3dalia/iStock

What would you do if you discovered your name in a list of experts on sex robots despite having never studied sex robots? 

That was the situation for one rather panicked researcher who reached out to us in late September after discovering his name among several singled out in a review article for the “greatest number of published works” on sex robots. 

Published in February in Humanities and Social Sciences Communications, the bibliometric analysis of the field aimed “to provide a clearer understanding of the issues surrounding sex robots,” the original article stated. 

Continue reading A peer-reviewed paper claimed a researcher was an expert in sex robots. He’s not.

Weekend reads: PubMed during the US shutdown; EU commissioner ‘appears to cite’ discredited study; KPMG corrected ‘phantom’ reference in gov’t report

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up past 500. There are more than 60,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: PubMed during the US shutdown; EU commissioner ‘appears to cite’ discredited study; KPMG corrected ‘phantom’ reference in gov’t report

Soil scientist previously named in citation scandal appointed to editor role at Elsevier journal

Artemi Cerdà

A soil scientist who resigned from several journals in 2017 after being linked to manipulated citations has been appointed to the editorial board of a journal copublished by Elsevier and China Science Publishing & Media.

International Soil and Water Conservation Research announced in April that Artemi Cerdà would serve as an editorial board member, describing him as a “renowned researcher” in the field of soil erosion and land management. The appointment comes eight years after Cerdà, of the University of Valencia, in Spain, was found to have manipulated citations in favor of his own work and journals with which he was associated. 

While Cerdà has not responded to our questions about his appointment, a spokesperson for Elsevier acknowledged Cerdà’s history but defended the decision, writing that researchers “grow into their roles through participation and learning.” The spokesperson continued:

Continue reading Soil scientist previously named in citation scandal appointed to editor role at Elsevier journal